Advertisement
Canada markets open in 2 hours 1 minute

  • S&P/TSX

    21,708.44
    +52.39 (+0.24%)
     

  • S&P 500

    5,011.12
    -11.09 (-0.22%)
     

  • DOW

    37,775.38
    +22.07 (+0.06%)
     

  • CAD/USD

    0.7262
    -0.0001 (-0.02%)
     

  • CRUDE OIL

    81.91
    -0.82 (-0.99%)
     

  • Bitcoin CAD

    89,340.38
    +2,677.60 (+3.09%)
     

  • CMC Crypto 200

    1,337.78
    +25.16 (+1.96%)
     

  • GOLD FUTURES

    2,389.60
    -8.40 (-0.35%)
     

  • RUSSELL 2000

    1,942.96
    -4.99 (-0.26%)
     

  • 10-Yr Bond

    4.6470
    0.0000 (0.00%)
     

  • NASDAQ futures

    17,462.00
    -85.25 (-0.49%)
     

  • VOLATILITY

    19.40
    +1.40 (+7.77%)
     

  • FTSE

    7,823.66
    -53.39 (-0.68%)
     

  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

  • CAD/EUR

    0.6817
    -0.0004 (-0.06%)
     

Agile Therapeutics to Report First Quarter 2023 Financial Results and Provide Business Update on Thursday, May 11, 2023

Agile Therapeutics, Inc.
·1 min read
Agile Therapeutics, Inc.
Agile Therapeutics, Inc.

Live Conference Call and Webcast at 4:30 p.m. ET

PRINCETON, N.J., May 08, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced it will report first quarter 2023 financial results after the market close on Thursday, May 11, 2023. Following the release, the Company will host a live conference call and webcast at 4:30 p.m. ET to discuss the Company’s financial results and provide a business update.

Event

Agile Therapeutics First Quarter 2023 Financial Results Conference Call

Date

Thursday, May 11, 2023

Time

4:30 p.m. ET / 1:30 p.m. PT

 

 

A live webcast of the conference call may be accessed via the Investor Relations portion of the Agile Therapeutics website at https://ir.agiletherapeutics.com/events-and-presentations. To participate in the live conference call via telephone, please register here. Upon registering, a dial-in number and unique PIN will be provided to join the conference call.

ADVERTISEMENT

About Agile Therapeutics, Inc.

Agile Therapeutics is a women's healthcare company dedicated to fulfilling the unmet health needs of today’s women. Our product and product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method. Our initial product, Twirla®, (levonorgestrel and ethinyl estradiol) transdermal system, is a non-daily prescription contraceptive. Twirla is based on our proprietary transdermal patch technology, called Skinfusion®, which is designed to allow drug delivery through the skin. For more information, please visit the company website at www.agiletherapeutics.com. The Company may occasionally disseminate material, nonpublic information on the Company’s website, Twitter account (@agilether), and LinkedIn account.

Contact:
Matt Riley
Head of Investor Relations & Corporate Communications
mriley@agiletherapeutics.com